
Cilta-cel Elicits an ORR of 100% in Multiple Myeloma After Early Relapse on Initial Therapy
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNWG5Qd0VzNjk5dlZzSVB6S2I0d0UzWWptdFpwQWlHeVFXMDBhajE5M2VzYkxXbHZTY2YtazUyS2NPclliaFVqOTJUdHJzUFlQanFfdVRaWHNwNU91bVVVQ3lUQmJhSVNWWjBNZlp4NzBFTFFrVFVCUHBhNlY0LXlsQmpjWTA1ZUxEOEIwVWU2b2g5blJHMWxxcXo0VTkwbjJScnpLRFpHdGJ1M1BmSGtuY1N1MHB3QlJmWUdV?oc=5" target="_blank">Cilta-cel Elicits an ORR of 100% in Multiple Myeloma After Early Relapse on Initial Therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>